4-( N -Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition
To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinan...
Saved in:
Published in | Biomolecules (Basel, Switzerland) Vol. 10; no. 8; p. 1094 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
Switzerland
MDPI AG
23.07.2020
MDPI Multidisciplinary Digital Publishing Institute (MDPI) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with
values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL. |
---|---|
AbstractList | To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with Ki values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL. To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL. To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with K i values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL. To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with K i values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL. |
Author | Legru, Alice Feller, Georges Gavara, Laurent Verdirosa, Federica Sannio, Filomena Tanfoni, Silvia Sevaille, Laurent Mercuri, Paola Sandra Docquier, Jean-Denis Galleni, Moreno Nauton, Lionel Hernandez, Jean-François Marcoccia, Francesca Gresh, Nohad Berthomieu, Dorothée De Luca, Filomena |
AuthorAffiliation | 4 Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France; lionel.nauton@uca.fr 1 Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France; alice.legru@umontpellier.fr (A.L.); laurent.sevaille@curie.fr (L.S.) 2 Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy; federica.verdirosa@student.unisi.it (F.V.); filomena.sannio@unisi.it (F.S.); francesca.marcoccia@unisi.it (F.M.); tanfoni.silvia@gmail.com (S.T.); deluca19@unisi.it (F.D.L.) 6 Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France; dorothee.berthomieu@enscm.fr 3 Laboratoire des Macromolécules Biologiques, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium; pmercuri@uliege.be (P.S.M.); mgalleni@uliege.be (M.G.) 5 Laboratoire de Bioc |
AuthorAffiliation_xml | – name: 6 Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France; dorothee.berthomieu@enscm.fr – name: 3 Laboratoire des Macromolécules Biologiques, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium; pmercuri@uliege.be (P.S.M.); mgalleni@uliege.be (M.G.) – name: 1 Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France; alice.legru@umontpellier.fr (A.L.); laurent.sevaille@curie.fr (L.S.) – name: 2 Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy; federica.verdirosa@student.unisi.it (F.V.); filomena.sannio@unisi.it (F.S.); francesca.marcoccia@unisi.it (F.M.); tanfoni.silvia@gmail.com (S.T.); deluca19@unisi.it (F.D.L.) – name: 4 Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France; lionel.nauton@uca.fr – name: 5 Laboratoire de Biochimie, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, B6, Sart-Tilman, 4000 Liège, Belgium; gfeller@uliege.be – name: 7 Laboratoire de Chimie Théorique, UMR7616, Sorbonne Université, CNRS, 75252 Paris, France; gresh@lct.jussieu.fr |
Author_xml | – sequence: 1 givenname: Laurent surname: Gavara fullname: Gavara, Laurent organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France – sequence: 2 givenname: Federica surname: Verdirosa fullname: Verdirosa, Federica organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 3 givenname: Alice surname: Legru fullname: Legru, Alice organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France – sequence: 4 givenname: Paola Sandra surname: Mercuri fullname: Mercuri, Paola Sandra organization: Laboratoire des Macromolécules Biologiques, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium – sequence: 5 givenname: Lionel orcidid: 0000-0003-0668-4063 surname: Nauton fullname: Nauton, Lionel organization: Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France – sequence: 6 givenname: Laurent orcidid: 0000-0002-2347-2495 surname: Sevaille fullname: Sevaille, Laurent organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France – sequence: 7 givenname: Georges orcidid: 0000-0001-8660-0944 surname: Feller fullname: Feller, Georges organization: Laboratoire de Biochimie, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, B6, Sart-Tilman, 4000 Liège, Belgium – sequence: 8 givenname: Dorothée surname: Berthomieu fullname: Berthomieu, Dorothée organization: Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France – sequence: 9 givenname: Filomena orcidid: 0000-0003-3001-8159 surname: Sannio fullname: Sannio, Filomena organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 10 givenname: Francesca surname: Marcoccia fullname: Marcoccia, Francesca organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 11 givenname: Silvia surname: Tanfoni fullname: Tanfoni, Silvia organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 12 givenname: Filomena surname: De Luca fullname: De Luca, Filomena organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 13 givenname: Nohad surname: Gresh fullname: Gresh, Nohad organization: Laboratoire de Chimie Théorique, UMR7616, Sorbonne Université, CNRS, 75252 Paris, France – sequence: 14 givenname: Moreno surname: Galleni fullname: Galleni, Moreno organization: Laboratoire des Macromolécules Biologiques, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium – sequence: 15 givenname: Jean-Denis orcidid: 0000-0001-9483-4476 surname: Docquier fullname: Docquier, Jean-Denis organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy – sequence: 16 givenname: Jean-François surname: Hernandez fullname: Hernandez, Jean-François organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32717907$$D View this record in MEDLINE/PubMed https://hal.science/hal-02997710$$DView record in HAL |
BookMark | eNpdkt1qFDEUxwep2Fp757UMeNPCRjP5mMx4ISxF7cL6ASp4F5LMmd1sM8mamV1YX8W38EF8JrMflm1DIIeT__mdP8l5mp344CHLnhf4FaU1fq1t6AqMqwLX7FF2RkhRISLoj5Oj-DS76PsFTqtKm9An2SklohA1FmfZb4Yu8085GrvbjUO58k2KTQpVZ324QsWIjBgaolW_ggNE0TC3yUI-9sqFWZ-rPv8Ig3IuoL9_0FSZQXWqh3zi51bbIcT-TT7plimfhzZnaGr9LcQ8-PxLGMCbza7l1yWYIa66reZQmbo8yx63yvVwcTjPs-_v3327vkHTzx8m1-MpMpyXAwIgStEGWNXighANNa44VqA4A0obppkA3NCW8ZKXpKalVqoVXHOBC8GEoefZZM9tglrIZbSdihsZlJW7RIgzqeJgjQOZsBog8Stes0bpqtR1C3Vbgmk1UW1ivd2zlivdQWPAD1G5e9D7N97O5SyspWAlr6oyAege4CzMIDXXVq7JrnAXr1xyY6QGSUhZScJqUfNUdbWvmj9odjOeym0Ok7oWosDrImkvDxZj-LmCfpCd7Q04pzyEVZ-QpMJlSegW-_KBdBFWMX39TiV4RZOJpBrtVSaGvo_Q3jkosNyOqTwe0yR_cfxEd-L_Q0n_AdNU45k |
CitedBy_id | crossref_primary_10_1002_cmdc_202100699 crossref_primary_10_1016_j_ejmech_2022_114677 crossref_primary_10_3390_biom11070986 crossref_primary_10_3390_molecules27123832 crossref_primary_10_3390_ph14070612 crossref_primary_10_1016_j_ejmech_2021_113873 crossref_primary_10_1016_j_bmc_2022_116964 crossref_primary_10_1021_acs_jmedchem_2c01257 crossref_primary_10_3390_M1380 crossref_primary_10_1080_13543776_2023_2262763 crossref_primary_10_3390_antibiotics12020306 crossref_primary_10_1016_j_micres_2022_127079 crossref_primary_10_1016_j_bioorg_2021_105024 crossref_primary_10_1016_j_bioorg_2021_105138 |
Cites_doi | 10.1128/AAC.01963-19 10.1074/jbc.M104742200 10.1016/j.bmcl.2012.06.074 10.1097/MRM.0b013e3283587727 10.1128/AAC.00074-18 10.1002/jcc.21256 10.1128/AAC.01336-09 10.1002/cmdc.201700186 10.1021/acs.jpcb.7b01053 10.1016/S1473-3099(17)30753-3 10.1021/acs.jmedchem.9b01279 10.3109/14756366.2016.1172575 10.1016/j.bmcl.2011.10.116 10.1016/j.jmb.2007.10.036 10.1128/AAC.43.4.902 10.1021/jo400236f 10.1021/acsmedchemlett.7b00428 10.3390/ph13030052 10.1089/mdr.1996.2.253 10.1016/j.bmcl.2011.04.027 10.1128/AAC.01486-09 10.4155/fmc-2017-0007 10.1021/acs.jmedchem.9b01518 10.2147/IDR.S173867 10.1101/cshperspect.a025239 10.1093/jac/dkg067 10.1007/7355_2017_24 10.1016/j.drudis.2008.07.005 10.1128/AAC.01768-15 10.3389/fmicb.2018.02928 10.1042/BST0380888 10.1021/acs.jmedchem.7b00407 10.1016/j.drup.2017.11.002 10.1016/j.bmc.2005.11.046 10.1021/acsinfecdis.8b00247 10.1016/j.tips.2018.03.007 10.1016/j.pep.2005.01.016 10.1074/jbc.M414052200 10.1093/femsre/fuz014 10.1021/acs.jmedchem.9b01976 10.2174/1389450116666151001105622 10.1021/acs.jmedchem.5b01289 10.1254/jjp.63.187 10.1021/acs.jmedchem.9b00911 10.1039/b802311e 10.1002/cmdc.201402249 10.1038/s41579-019-0159-8 10.1002/jcc.20084 10.1038/nature13445 10.1016/S1074-5521(03)00070-X 10.1021/acsinfecdis.8b00246 10.1128/AAC.46.6.1823-1830.2002 10.1021/jm100213c 10.1093/jac/dkg126 |
ContentType | Journal Article Web Resource |
Copyright | 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution 2020 by the authors. 2020 |
Copyright_xml | – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution – notice: 2020 by the authors. 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7T5 7TM 7TO 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES Q33 5PM DOA |
DOI | 10.3390/biom10081094 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest Publicly Available Content database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) Université de Liège - Open Repository and Bibliography (ORBI) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2218-273X |
ExternalDocumentID | oai_doaj_org_article_0aebee0858594dab86b9fe9f6ecfb2af oai_orbi_ulg_ac_be_2268_249795 oai_HAL_hal_02997710v1 10_3390_biom10081094 32717907 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Agence Nationale de la Recherche grantid: ANR-14-CE16-0028-01 |
GroupedDBID | 3V. 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AADQD AAFWJ ABDBF ABUWG ADBBV AFKRA AFPKN AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CGR CUY CVF EBD ECM EIF ESX FYUFA GROUPED_DOAJ HCIFZ HMCUK HYE IAO KQ8 LK8 M1P M48 M7P MODMG M~E NPM OK1 PGMZT PIMPY PQQKQ PROAC PSQYO RIG RPM UKHRP AAYXX CITATION 7T5 7TM 7TO 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PQEST PQUKI PRINS 7X8 1XC VOOES ADRAZ IPNFZ ITC Q33 5PM |
ID | FETCH-LOGICAL-c556t-ee2aa3de48f0122be90850aea54e33d4b47e0d3f456562936baaf75b5701747c3 |
IEDL.DBID | RPM |
ISSN | 2218-273X |
IngestDate | Tue Oct 22 15:12:29 EDT 2024 Tue Sep 17 21:27:12 EDT 2024 Fri Nov 08 14:53:27 EST 2024 Tue Oct 15 15:52:48 EDT 2024 Sat Oct 26 05:58:23 EDT 2024 Thu Oct 10 20:32:52 EDT 2024 Thu Sep 26 21:29:24 EDT 2024 Sat Nov 02 12:27:03 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | β-lactam antibiotics 1,2,4-triazole-3-thione enzyme inhibitors metallo-β-lactamase bacterial resistance 4-triazole-3-thione 1 Metallo-β-lactamase 2 Enzyme inhibitors Bacterial resistance |
Language | English |
License | Attribution: http://creativecommons.org/licenses/by Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c556t-ee2aa3de48f0122be90850aea54e33d4b47e0d3f456562936baaf75b5701747c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC7465886 Grant ANR-14-CE16-0028-01 scopus-id:2-s2.0-85088573230 |
ORCID | 0000-0003-3001-8159 0000-0003-0668-4063 0000-0001-8660-0944 0000-0002-2347-2495 0000-0001-9483-4476 0000-0003-0146-1848 0000-0002-3818-105X 0000-0003-1609-2272 0000-0003-3560-9361 0000-0001-7174-2907 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465886/ |
PMID | 32717907 |
PQID | 2427583226 |
PQPubID | 2032425 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0aebee0858594dab86b9fe9f6ecfb2af pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465886 liege_orbi_v2_oai_orbi_ulg_ac_be_2268_249795 hal_primary_oai_HAL_hal_02997710v1 proquest_miscellaneous_2428066235 proquest_journals_2427583226 crossref_primary_10_3390_biom10081094 pubmed_primary_32717907 |
PublicationCentury | 2000 |
PublicationDate | 20200723 |
PublicationDateYYYYMMDD | 2020-07-23 |
PublicationDate_xml | – month: 7 year: 2020 text: 20200723 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Biomolecules (Basel, Switzerland) |
PublicationTitleAlternate | Biomolecules |
PublicationYear | 2020 |
Publisher | MDPI AG MDPI Multidisciplinary Digital Publishing Institute (MDPI) |
Publisher_xml | – name: MDPI AG – name: MDPI – name: Multidisciplinary Digital Publishing Institute (MDPI) |
References | Ventola (ref_8) 2015; 40 Freire (ref_52) 2008; 13 Bebrone (ref_43) 2005; 280 Morris (ref_47) 2009; 16 Feng (ref_59) 2012; 22 McGeary (ref_17) 2017; 9 Brindisi (ref_49) 2016; 31 Fernandes (ref_1) 2013; 24 Zhang (ref_61) 2014; 9 Sanner (ref_48) 1999; 17 Docquier (ref_40) 2002; 46 Fischer (ref_3) 2017; Volume 25 Makena (ref_16) 2016; 60 Everett (ref_28) 2018; 62 Peterson (ref_2) 2018; 9 Christopeit (ref_56) 2015; 58 Yang (ref_46) 2003; 51 ref_60 Bonomo (ref_11) 2017; 7 Christopeit (ref_62) 2016; 72 Olsen (ref_33) 2006; 14 Tacconelli (ref_9) 2018; 18 King (ref_22) 2014; 510 ref_24 Docquier (ref_41) 2003; 51 Vella (ref_55) 2011; 21 Ju (ref_13) 2018; 39 Liu (ref_26) 2020; 63 Krajnc (ref_27) 2019; 62 Laws (ref_5) 2019; 43 Galleni (ref_42) 1996; 2 Linciano (ref_15) 2019; 5 Spyrakis (ref_57) 2018; 9 Mojica (ref_14) 2016; 17 Lassaux (ref_19) 2010; 53 Lassaux (ref_50) 2011; 55 Nauton (ref_34) 2008; 375 Borgianni (ref_45) 2010; 54 Laraki (ref_39) 1999; 43 Leiris (ref_29) 2019; 5 Moali (ref_51) 2003; 10 ref_30 Ladbury (ref_53) 2010; 38 Bush (ref_12) 2019; 17 Sevaille (ref_35) 2017; 12 Worthington (ref_10) 2013; 78 ref_37 Zaman (ref_7) 2017; 9 Hamrick (ref_25) 2020; 64 Pettersen (ref_54) 2004; 25 Matsuura (ref_23) 1993; 63 Docquier (ref_31) 2018; 36 Aslam (ref_4) 2018; 11 Garau (ref_18) 2008; 6 Toney (ref_20) 2001; 276 ref_44 Studier (ref_38) 2005; 41 Faridoon (ref_58) 2012; 22 Chen (ref_21) 2017; 60 Pernas (ref_32) 2020; 63 Kwapien (ref_36) 2017; 121 ref_6 |
References_xml | – volume: 64 start-page: 1 year: 2020 ident: ref_25 article-title: VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamase, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01963-19 contributor: fullname: Hamrick – volume: 276 start-page: 31913 year: 2001 ident: ref_20 article-title: Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β-lactamase publication-title: J. Biol. Chem. doi: 10.1074/jbc.M104742200 contributor: fullname: Toney – volume: 22 start-page: 5185 year: 2012 ident: ref_59 article-title: N-Heterocyclic dicarboxylic acids: Broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2012.06.074 contributor: fullname: Feng – volume: 24 start-page: 7 year: 2013 ident: ref_1 article-title: β-Lactams: Chemical structure, mode of action and mechanisms of resistance publication-title: Rev. Med. Microbiol. doi: 10.1097/MRM.0b013e3283587727 contributor: fullname: Fernandes – volume: 62 start-page: 7 year: 2018 ident: ref_28 article-title: Discovery of a novel metallo-β-lactamase inhibitor that potentiates meropenem activity against carbapenem-resistant Enterobacteriaceae publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00074-18 contributor: fullname: Everett – volume: 16 start-page: 2785 year: 2009 ident: ref_47 article-title: AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility publication-title: J. Comput. Chem. doi: 10.1002/jcc.21256 contributor: fullname: Morris – volume: 54 start-page: 3197 year: 2010 ident: ref_45 article-title: Mutational analysis of VIM-2 reveals an essential determinant for metallo-β-lactamase stability and folding publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01336-09 contributor: fullname: Borgianni – volume: 12 start-page: 972 year: 2017 ident: ref_35 article-title: 1,2,4-Triazole-3-thione compounds as inhibitors of dizinc metallo-β-lactamases publication-title: Chem. Med. Chem. doi: 10.1002/cmdc.201700186 contributor: fullname: Sevaille – volume: 121 start-page: 6295 year: 2017 ident: ref_36 article-title: Calibration of 1,2,4-triazole-3-thione, an original Zn-binding group of metallo-β-lactamase inhibitors. Validation of a polarizable MM/MD potential by quantum chemistry publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.7b01053 contributor: fullname: Kwapien – volume: 18 start-page: 318 year: 2018 ident: ref_9 article-title: Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(17)30753-3 contributor: fullname: Tacconelli – volume: 63 start-page: 1859 year: 2020 ident: ref_32 article-title: β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.9b01279 contributor: fullname: Pernas – volume: 31 start-page: 98 year: 2016 ident: ref_49 article-title: Targeting clinically-relevant metallo-β-lactamases: From high-throughput docking to broad-spectrum inhibitors publication-title: J. Enzyme Inhib. Med. Chem. doi: 10.3109/14756366.2016.1172575 contributor: fullname: Brindisi – volume: 22 start-page: 383 year: 2012 ident: ref_58 article-title: 3-Mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.10.116 contributor: fullname: Faridoon – volume: 375 start-page: 257 year: 2008 ident: ref_34 article-title: Structural insights into the design of inhibitors for the L1 metallo-β-lactamase from Stenotrophomonas maltophilia publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2007.10.036 contributor: fullname: Nauton – volume: 43 start-page: 902 year: 1999 ident: ref_39 article-title: Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.43.4.902 contributor: fullname: Laraki – volume: 78 start-page: 4207 year: 2013 ident: ref_10 article-title: Overcoming resistance to β-lactam antibiotics publication-title: J. Org. Chem. doi: 10.1021/jo400236f contributor: fullname: Worthington – volume: 9 start-page: 45 year: 2018 ident: ref_57 article-title: Structure-based virtual screening for the discovery of novel inhibitors of New Delhi Metallo-β-lactamase-1 publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.7b00428 contributor: fullname: Spyrakis – ident: ref_60 doi: 10.3390/ph13030052 – volume: 2 start-page: 253 year: 1996 ident: ref_42 article-title: Overproduction and purification of the Aeromonas hydrophila CphA metallo-β-lactamse expressed in Escherichia coli publication-title: Microb. Drug Resist. doi: 10.1089/mdr.1996.2.253 contributor: fullname: Galleni – volume: 21 start-page: 3282 year: 2011 ident: ref_55 article-title: The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.04.027 contributor: fullname: Vella – volume: 55 start-page: 1248 year: 2011 ident: ref_50 article-title: Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01486-09 contributor: fullname: Lassaux – volume: 9 start-page: 1 year: 2017 ident: ref_7 article-title: A review on antibiotic resistance: Alarm bells are ringing publication-title: Cureus contributor: fullname: Zaman – volume: 9 start-page: 673 year: 2017 ident: ref_17 article-title: Progress toward inhibitors of metallo-β-lactamases publication-title: Future Med. Chem. doi: 10.4155/fmc-2017-0007 contributor: fullname: McGeary – volume: 63 start-page: 2789 year: 2020 ident: ref_26 article-title: Discovery of Taniborbactam (VNRX-5133): A broad-spectrum serine- and metallo-β-lactamase inhibitor for carbapenem-resistant bacterial infections publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.9b01518 contributor: fullname: Liu – volume: 11 start-page: 1645 year: 2018 ident: ref_4 article-title: Antibiotic resistance: A rundown of a global crisis publication-title: Infect. Drug Resist. doi: 10.2147/IDR.S173867 contributor: fullname: Aslam – volume: 7 start-page: 1 year: 2017 ident: ref_11 article-title: β-Lactamases: A focus on current challenges publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a025239 contributor: fullname: Bonomo – volume: 17 start-page: 57 year: 1999 ident: ref_48 article-title: Python: A programming language for software integration and development publication-title: J. Mol. Graph. Mod. contributor: fullname: Sanner – volume: 51 start-page: 257 year: 2003 ident: ref_41 article-title: On functional and structural heterogeneity of VIM-type metallo-β-lactamases publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkg067 contributor: fullname: Docquier – volume: Volume 25 start-page: 31 year: 2017 ident: ref_3 article-title: The antibiotic future publication-title: Antibacterials doi: 10.1007/7355_2017_24 contributor: fullname: Fischer – volume: 40 start-page: 277 year: 2015 ident: ref_8 article-title: The antibiotic resistance crisis. Part 1: Causes and Threats publication-title: Pharm. Ther. contributor: fullname: Ventola – ident: ref_24 – volume: 13 start-page: 869 year: 2008 ident: ref_52 article-title: Do enthalpy and entropy distinguish first class from best in class? publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2008.07.005 contributor: fullname: Freire – volume: 60 start-page: 1377 year: 2016 ident: ref_16 article-title: Comparison of Verona Integron-borne Metallo-β-lactamase (VIM) variants reveals differences in stability and inhibition profiles publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01768-15 contributor: fullname: Makena – volume: 9 start-page: 2928 year: 2018 ident: ref_2 article-title: Antibiotic resistance mechanisms in bacteria: Relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens publication-title: Front. Microbiol. doi: 10.3389/fmicb.2018.02928 contributor: fullname: Peterson – volume: 38 start-page: 888 year: 2010 ident: ref_53 article-title: Calorimetry as a tool for understanding biomolecular interactions and an aid to drug design publication-title: Biochem. Soc. Trans. doi: 10.1042/BST0380888 contributor: fullname: Ladbury – volume: 60 start-page: 7267 year: 2017 ident: ref_21 article-title: Dipicolinic acid derivatives as inhibitors of New Delhi Metallo-β-lactamase-1 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.7b00407 contributor: fullname: Chen – ident: ref_37 – volume: 36 start-page: 13 year: 2018 ident: ref_31 article-title: An update on β-lactamase inhibitor discovery and development publication-title: Drug Resist. Update doi: 10.1016/j.drup.2017.11.002 contributor: fullname: Docquier – volume: 14 start-page: 2627 year: 2006 ident: ref_33 article-title: New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2005.11.046 contributor: fullname: Olsen – ident: ref_44 – volume: 5 start-page: 9 year: 2019 ident: ref_15 article-title: Ten years with New Delhi Metallo-β-Lactamase-1 (NDM-1): From structural insights to inhibitor design publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.8b00247 contributor: fullname: Linciano – volume: 39 start-page: 635 year: 2018 ident: ref_13 article-title: The continuing challenge of metallo-β-lactamase inhibition: Mechanism matters publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2018.03.007 contributor: fullname: Ju – volume: 41 start-page: 207 year: 2005 ident: ref_38 article-title: Protein production by auto-induction in high density shaking cultures publication-title: Protein Expr. Purif. doi: 10.1016/j.pep.2005.01.016 contributor: fullname: Studier – volume: 280 start-page: 28195 year: 2005 ident: ref_43 article-title: Dramatic broadening of the substrate profile of the Aeromonas hydrophila CphA metallo-β-lactamase by site-directed mutagenesis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M414052200 contributor: fullname: Bebrone – volume: 43 start-page: 490 year: 2019 ident: ref_5 article-title: Antibiotic resistance breakers: Current approaches and future directions publication-title: FEMS Microbiol. Rev. doi: 10.1093/femsre/fuz014 contributor: fullname: Laws – ident: ref_30 doi: 10.1021/acs.jmedchem.9b01976 – volume: 17 start-page: 1029 year: 2016 ident: ref_14 article-title: B1-Metallo-β-lactamases: Where do we stand? publication-title: Curr. Drug Targets doi: 10.2174/1389450116666151001105622 contributor: fullname: Mojica – ident: ref_6 – volume: 58 start-page: 8671 year: 2015 ident: ref_56 article-title: Discovery of novel inhibitor scaffolds against the metallo-β-lactamase VIM-2 by surface plasmon resonance (SPR) based fragment screening publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b01289 contributor: fullname: Christopeit – volume: 63 start-page: 187 year: 1993 ident: ref_23 article-title: Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors publication-title: JPN J. Pharmacol. doi: 10.1254/jjp.63.187 contributor: fullname: Matsuura – volume: 62 start-page: 8544 year: 2019 ident: ref_27 article-title: Bicyclic boronate VNRX-5133 inhibits metallo- and serine β-lactamases publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.9b00911 contributor: fullname: Krajnc – volume: 6 start-page: 2282 year: 2008 ident: ref_18 article-title: Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiols publication-title: Org. Biomol. Chem. doi: 10.1039/b802311e contributor: fullname: Garau – volume: 9 start-page: 2445 year: 2014 ident: ref_61 article-title: Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi Metallo-β-lactamase-1 (NDM-1) publication-title: Chem. Med. Chem. doi: 10.1002/cmdc.201402249 contributor: fullname: Zhang – volume: 17 start-page: 295 year: 2019 ident: ref_12 article-title: Interplay between β-lactamases and new β-lactamase inhibitors publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-019-0159-8 contributor: fullname: Bush – volume: 25 start-page: 1605 year: 2004 ident: ref_54 article-title: UCSF Chimera-A visualization system for exploratory research and analysis publication-title: J. Comput. Chem. doi: 10.1002/jcc.20084 contributor: fullname: Pettersen – volume: 510 start-page: 503 year: 2014 ident: ref_22 article-title: Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance publication-title: Nature doi: 10.1038/nature13445 contributor: fullname: King – volume: 10 start-page: 319 year: 2003 ident: ref_51 article-title: Analysis of the importance of the metallo-β-lactamase active site loop in substrate binding and catalysis publication-title: Chem. Biol. doi: 10.1016/S1074-5521(03)00070-X contributor: fullname: Moali – volume: 5 start-page: 131 year: 2019 ident: ref_29 article-title: SAR studies leading to the identification of a novel series of metallo-β-lactamase inhibitors for the treatment of carbapenem-resistant Enterobacteriaceae infections that display efficacy in an animal infection model publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.8b00246 contributor: fullname: Leiris – volume: 46 start-page: 1823 year: 2002 ident: ref_40 article-title: CAU-1, a subclass B3 metallo-β-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.46.6.1823-1830.2002 contributor: fullname: Docquier – volume: 53 start-page: 4862 year: 2010 ident: ref_19 article-title: Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-β-lactamases publication-title: J. Med. Chem. doi: 10.1021/jm100213c contributor: fullname: Lassaux – volume: 51 start-page: 545 year: 2003 ident: ref_46 article-title: Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkg126 contributor: fullname: Yang – volume: 72 start-page: 813 year: 2016 ident: ref_62 article-title: The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor publication-title: Acta Cryst. contributor: fullname: Christopeit |
RestrictionsOnAccess | restricted access |
SSID | ssj0000800823 |
Score | 2.3074496 |
Snippet | To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report... |
SourceID | doaj pubmedcentral liege hal proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1094 |
SubjectTerms | 1,2,4-triazole-3-thione Anti-Bacterial Agents Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibiotics Bacteria Bacterial Infections Bacterial Infections - microbiology Bacterial Infections - prevention & control bacterial resistance Beta-Lactamase Inhibitors beta-Lactamase Inhibitors - chemistry beta-Lactamase Inhibitors - pharmacology Beta-Lactamases beta-Lactamases - metabolism Beta-Lactams beta-Lactams - chemistry beta-Lactams - pharmacology Biocatalysis Biocatalysis - drug effects Biochemistry, biophysics & molecular biology Biochimie, biophysique & biologie moléculaire Calorimetry Carbapenems Carbapenems - chemistry Carbapenems - pharmacology Chemical Sciences Drug development Drug resistance Drug Resistance, Bacterial Drug Resistance, Bacterial - drug effects enzyme inhibitors Enzymes Gram-Negative Bacteria Gram-Negative Bacteria - drug effects Gram-Negative Bacteria - metabolism Humans Hydrazine Infections Life sciences Medicinal Chemistry Metallo-β-lactamase Microbial Sensitivity Tests Microbiologie Microbiology Molecular Structure Pathogens Physicochemical properties Sciences du vivant Thiones Thiones - chemistry Titration Triazoles Triazoles - chemistry Zinc β-Lactam antibiotics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQuXBBlPITWpBBgEBaq1nbiWNuC6LaorbiQKXeLDtx2IVsgrrZSsub8Bo8CM_EjJOuNgiJC9pLFM_aTmbs-fHkG0Ke6yRPC61LlvPCMpmMc-aKccZS7jDor0GpYLzj9CydnssPF8nFVqkvzAnr4IG7F3cYWxjGx3h8pWVhXZY6XXpdpj4vHbdl2H1jveVMfentoIyLLtNdgF9_iF-zI5AN0MqBDgpQ_aBZZpgIebPCo-q_WZt_Jk1uaaGjO-R2bz7SSTftXXLD13fJ3qQG13mxpi9pSOgMkfI98kOyV2dsUn1dV4zauqBsksOlXczr5jUbj_hIMiza8b2pPBOsnSFoEUWUkubzktolPfUtHsuzXz_Zic1buwCNR4_r2dzNsUbPG3ocPrGkTUklQ6fWX9Kmph8btMPXYUgsb99erhZI0_8TRrlHzo_ef3o3ZX0lBpYnSdoy77m1ovAyK_EoznmNSHfW20R6IQrppPJxIcpgHoIBkTprS5W4RMGClyoX98lODc_wkNAUIftU7rSX8HMYeAIfFHaCxI99lqUReXHNG_OtA9ww4KggD802DyPyFhm3oUGY7HADhMf0wmP-JTwReQZsH_QxnZwYvBeDnlZgfl2NIzIKUgE9u7m54oEsXK8qGCo3zhswYjMDnqzSSUQOroXH9PvBEpo4OGawecLzPd00w0rG4xlb-2YVaDLE4xfQxYNO1jYzE1whlJqKiBpI4WDqw5Z6Pgto4UqCkZmlj_7H-9ontzjGG2LFuDggOyBA_jEYZa17EtbfbySWNtY priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Complete (ProQuest Database) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dbtMwFLZgu-EGAeMnMJBBgECqtSR27IQbVBBTh7aJCyb1zrIdZ63WJqNNJ5U34TV4EJ6Jc9y0rAih3ESxYzs6xz6_-Q4hL4vMybIoKubS0jCRJY7ZMsmZTC06_QsQKujvODmVgzPxeZgNO4fbvEurXJ-J4aAuG4c-8gMQJaDaAvvJ95ffGFaNwuhqV0LjJtlN0lhiSpcaqo2PBbWhPOWrfHcO1v0B_tOOcDZJXIgtSRQA-0G-jDAdcneCAet_6Zx_p05ek0WHd8jtTomk_RXV75Ibvr5H9vo1GNDTJX1NQ1pn8JfvkR-CvTll_cnFcsKoqUvK-g5uzXRcN29Z0kt7gmHpju_NxDPO2hFCF1HEKmnO59TM6YlvMTjPfv1kx8a1Zgpyjx7Vo7EdY6Wed_Qo_GhJm4oKhqatn9Gmpl8a1MaXYUosct_OFlPs070Js9wnZ4efvn4csK4eA3NZJlvmfWoML73IKwzIWV8g3p3xJhOe81JYoXxc8iooiaBGSGtMpTKbKdj2Qjn-gOzU8A2PCJUI3KecLbyAy6L7CSxROA8yn_g8lxF5taaNvlzBbmgwV5CG-joNI_IBCbfpg2DZ4UEzO9fd3tOwROt9jBHQQpTG5tIWlS8q6V1lU1NF5AWQfWuMQf9Y47MYpLUCJewqiUgvcAWMbMf6Kg3dwv1iAlM5bb0G5sw12LOqyCKyv2Ye3Z0Kc_2HhyPyfNMM-xmDNKb2zSL0yRGVn8MQD1e8tlkZTxUCqqmIqC0u3Fr6dks9HgXMcCVA1czl4_8v6wm5laI_IVYs5ftkB1jDPwWlq7XPws76DSqLK9g priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3rbtMwFLbGJqH9QcC4BAYyCBBIMzSOEydICBXE1KFtQoJK-2fZyclaSBPoZaK8Cm_Bg_BMnOOm1QpD_WPFju3Uxz7f58tnxh5lcZ4UWVaKXBZWqDjMhSvCVCTS0aR_hk6F5juOjpNeX70_iU822PK20fYPnFxI7eg-qf64ev792_w1dvhXxDiRsr-gg-qkURMiVbnEtqRCjk6b-Fqg_7nFRamMFjvf_3lpm12OpCatKr3mnryKPzqdAe2R3KpoFfsiIPr3fspzDmr_KrvSIkveXZjCNbYB9XW2062RVY_m_An3ez39JPoO-6nEU37MRbf6Mq8Et3WB4RyDdjSsm2ci3JN7StCNHj-aCkQkpgNSNOIkYdKcTrid8COY0pq9-P1LHNp8akfoDvlBPRi6IV3g85If-POXvCm5EsR4Ycybmn9oCKTPfZEf6ZTneDaiNO2bWMoN1t9_9-ltT7TXNIg8jpOpAJDWRgWotKR1OgcZyeBZsLGCKCqUUxo6RVR67IjoInHWljp2scbRQOk8usk2a_yG24wnpOenc5eBwp-jWSkkqDhMxBBCmiYBe7xsHfN1ocZhkMVQg5rzDRqwN9R0qzSkoe0fNONT03ZJg1V0AB1aGM1UYV2auKyErEwgL520ZcAeYsOv5dHrHhp61kEnrhGbnYUB2_N2gTm7oTmTPpkPzyosKjcODCLc1CDN1VkcsN2l-ZilrWOURNaGIyt-34NVNHZzWruxNTQznyYlsf4Is7i1sLZVzZa2GzC9ZodrVV-PqYcDLyWuFSLQNLnz3zzvsm1JMwwdLWS0yzbRKuAewrCpu-972B-nnC6S priority: 102 providerName: Scholars Portal |
Title | 4-( N -Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32717907 https://www.proquest.com/docview/2427583226 https://search.proquest.com/docview/2428066235 https://hal.science/hal-02997710 http://orbi.ulg.ac.be/handle/2268/249795 https://pubmed.ncbi.nlm.nih.gov/PMC7465886 https://doaj.org/article/0aebee0858594dab86b9fe9f6ecfb2af |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kdBeEDBggVEZBAikeW0SJ05466ZNHVqrCjGpb5HtOGsgl6mXSeWf8Df4IfwmznHTqkU8oUhRFDu2o3OOz8XHnwl5Gwc6TOM4Y9pLJeOBq5lK3YiFnsKgfwxKBeMd_UHYu-GfR8FohwSrvTA2aV-r_LQqytMqH9vcyrtSt1d5Yu1h_1xw0JtR2N4lu8CgGy76t8YEijx_meTug0vfxo3siGHjgitzQB74nkBYKrGliSxgP-iXMaZD7he4YP0vm_Pv1MkNXXT5iDxsjEjaXQ72Mdkx1RNy2K3AgS4X9D21aZ02Xn5IfnL2YcC6xfdFwaisUsq6Gh5lmVf1R-aeeCec4dEdP-rCMJ_NxghdRBGrpL6dUjmlfTPDxXn2-xe7lnomS9B79Koa5yrHk3o-0Su70ZLWGeUMXVszoXVFhzVa4wvbJR5yP5vMS6zTfAm9PCU3lxdfz3usOY-B6SAIZ8wYT0o_NTzKcEFOmRjx7qSRATe-n3LFhemkfmaNRDAjQiVlJgIVCBB7LrT_jOxV8A9HhIYI3Ce0ig2HS2H4CTxRmA8C4xogrUPerWiT3C1hNxJwV5CcySY5HXKGhFvXQbBs-6Ke3CYNyyQwRGVMB1dAY55KFYUqzkychUZnypOZQ94A2bfa6HWvE3zXAW0twAi7dx1yYrkCWlZ5cu_ZavZ5XkBXOlEmAVM2SsCfFXHgkOMV8yTNrDCFIg_cM5hC4f9er4tBnnGRRlamnts6EaLy-9DE8yWvrUe24lyHiC0u3Br6dgmIkMUMb0TmxX9_-ZIceBhq6Ajm-cdkD7jGvAJ7bKZaIIUj0SL7ZxeD4ZeWjWrAvc-jlpXMP0_LOTs |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,74073,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZge4AXBAxYYIBBgECqtSZ24pgXVBBTC23Fwyb1zbITZ61ok9Gmk8o_4W_wQ_hN3LlpWRFCfYkS13Z0Z993d853hLxQcZbkShUsi3LDRBxmzOZhypLIYtBfgVHBeMdgmHTPxKdRPGoCbovmWOVmT_QbdV5lGCM_BlMC0BbUL3l38Y1h1SjMrjYlNK6TfeThwgoGciS3MRZEQ2nE1-fdOXj3x_hNO9LZhG0ldiyRJ-wH-zLG45D7U0xY_wtz_n108ootOrlNbjUgknbWUr9DrrnyLjnolOBAz1b0FfXHOn28_ID8EOz1kHWmX1dTRk2ZU9bJ4NLMJmX1hoWtqCUYlu74Xk0d46weI3URRa6S6nxBzYIOXI3JefbrJ-ubrDYzsHu0V44ndoKVet7Snv_QklYFFQxdWzenVUm_VIjGV35ILHJfz5czbNP8E0a5R85OPp5-6LKmHgPL4jipmXORMTx3Ii0wIWedQr4740wsHOe5sEK6ds4LDxIBRiTWmELGNpaw7IXM-H2yV8I7HBKaIHGfzKxyAn4Ww0_gicJ-ELvQpWkSkJcb2eiLNe2GBncFZaivyjAg71Fw2zZIlu1vVPNz3aw9DVO0zrUxA6pEbmyaWFU4VSQuK2xkioA8B7Hv9NHt9DXea4O1lgDCLsOAtLxWQM92oi8j38xfL6cwVKat06CcqQZ_Vqo4IEcb5dHNrrDQf3Q4IM-2j2E9Y5LGlK5a-jYpsvJz6OLBWte2M-ORREI1GRC5o4U7U999Uk7GnjNcCoCaafLw_9N6Sm50Twd93e8NPz8iNyOMLbQli_gR2QM1cY8BgNX2iV9lvwFQbS6_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dbtMwFLZgkxA3CBg_gQEGAQKpVpvYiWNuUPmpWuiqXTBpd5adOGtFm4w2nVTehNfgQXgmznHTsiKEehMlru3oHJ__fIeQ5yrOklypgmVRbpiIw4zZPExZElkM-itQKhjvOBol_RPx6TQ-beqfFk1Z5UYmekGdVxnGyNugSsC0BfZL2kVTFnH8off2_BvDDlKYaW3aaVwl-xK8FOR5eSq38Ra0jNKIr2vfOXj6bfy-HaFtwo4SO1rJg_eDrhljaeT-FJPX_7I__y6jvKSXejfJjcagpN01B9wiV1x5mxx0S3CmZyv6kvoSTx87PyA_BHs1Yt3p19WUUVPmlHUzuDSzSVm9ZmEragmGbTy-V1PHOKvHCGNEEbekOltQs6BHrsZEPfv1kw1NVpsZ6EA6KMcTO8GuPW_owH90SauCCoZurpvTqqTHFVrmK78kNryv58sZjmn-CavcISe9j1_e91nTm4FlcZzUzLnIGJ47kRaYnLNOIfadcSYWjvNcWCFdJ-eFNxjBpEisMYWMbSxBBAiZ8btkr4R3uE9ogiB-MrPKCfhZDEWBVwqyIXahS9MkIC82tNHnawgODa4L0lBfpmFA3iHhtmMQONvfqOZnujmHGrZonetgNlSJ3Ng0sapwqkhcVtjIFAF5BmTfmaPfHWq81wHNLcEguwgD0vJcATPbib6I_DB_vZzCUpm2TgOjphp8W6nigBxumEc3EmKh__BzQJ5uH8PZxoSNKV219GNSROjnMMW9Na9td8YjieBqMiByhwt3tr77pJyMPX64FGB2psmD_2_rCbkGB0wPB6PPD8n1CMMMHckifkj2gEvcI7DFavvYH7LfowQy9w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=4-%28+N+-Alkyl-+and+-Acyl-amino%29-1%2C2%2C4-triazole-3-thione+Analogs+as+Metallo-%CE%B2-Lactamase+Inhibitors%3A+Impact+of+4-Linker+on+Potency+and+Spectrum+of+Inhibition&rft.jtitle=Biomolecules+%28Basel%2C+Switzerland%29&rft.au=Gavara%2C+Laurent&rft.au=Verdirosa%2C+Federica&rft.au=Legru%2C+Alice&rft.au=Mercuri%2C+Paola+Sandra&rft.date=2020-07-23&rft.eissn=2218-273X&rft.volume=10&rft.issue=8&rft_id=info:doi/10.3390%2Fbiom10081094&rft_id=info%3Apmid%2F32717907&rft.externalDocID=32717907 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-273X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-273X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-273X&client=summon |